Brilliant blue g - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for brilliant blue g and what is the scope of patent protection?
Brilliant blue g
is the generic ingredient in one branded drug marketed by Dutch Ophthalmic and is included in one NDA. Additional information is available in the individual branded drug profile pages.One supplier is listed for this compound.
Summary for brilliant blue g
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 90 |
| Clinical Trials: | 6 |
| Patent Applications: | 2,398 |
| What excipients (inactive ingredients) are in brilliant blue g? | brilliant blue g excipients list |
| DailyMed Link: | brilliant blue g at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for brilliant blue g
Generic Entry Date for brilliant blue g*:
Constraining patent/regulatory exclusivity:
INDICATED TO SELECTIVELY STAIN THE INTERNAL LIMITING MEMBRANE (ILM) Dosage:
SOLUTION;OPHTHALMIC |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for brilliant blue g
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | N/A |
| Anthera Pharmaceuticals | Phase 3 |
| Asociación para Evitar la Ceguera en México | Phase 3 |
US Patents and Regulatory Information for brilliant blue g
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dutch Ophthalmic | TISSUEBLUE | brilliant blue g | SOLUTION;OPHTHALMIC | 209569-001 | Dec 20, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Dutch Ophthalmic | TISSUEBLUE | brilliant blue g | SOLUTION;OPHTHALMIC | 209569-001 | Dec 20, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
